Yield of esophagogastroduodenoscopy and colonoscopy in cancer of unknown primary
- PMID: 24353569
- PMCID: PMC3809229
- DOI: 10.12669/pjms.292.3212
Yield of esophagogastroduodenoscopy and colonoscopy in cancer of unknown primary
Abstract
Objectives: Carcinoma of unknown primary origin (CUP) is heterogeneous group of cancers. Role of gastrointestinal (GI) endoscopy in this entity is under investigated. Aim of this study was to evaluate yield of Colonoscopy and Esophagogastroduodenoscopy (EGD) in localizing primary tumor in patients with CUP.
Methodology: Patients with histopathologically proven CUP who underwent colonoscopy / EGD to find the primary tumor from December 2009 to December 2011 were included in the study. Abdominal symptoms and cytokeratin (CK) 7 and 20 markers were correlated with presence of primary in GI tract.
Results: After giving informed consent 86 patients were included in final analysis. All patients underwent colonoscopy while 60(70%) got EGD along with colonoscopy. Mean age was 55.10 +/-11.94 years with 52(60%) male. Abdominal symptoms were present in 50%. CK7+/CK20- in 34(40%); CK7-/CK20+ in 2(2%) while CK7+/20+ in 7(8%) of metastatic tumor samples. Liver was metastatic site in 47(55%), Lymph node 12(14%) and Ascites in 8(9%). Endoscopy detected primary in 6 (7%) patients with 3 each in stomach and colon. No association of abdominal symptoms and cytokeratin markers was found with presence of GI primary site.
Conclusion: Yield of localizing primary lesion in the GI tract by pan-endoscopy was limited. Abdominal symptoms and cytokeratin markers do not predict presence of gastrointestinal malignancies.
Keywords: Cancer of unknown primary (CUP); Colonoscopy; Esophagogasrtoduodenoscopy (EGD).
Similar articles
-
Prospective evaluation of gastrointestinal lesions by bidirectional endoscopy in patients with iron deficiency anemia.J Med Assoc Thai. 2011 Nov;94(11):1321-6. J Med Assoc Thai. 2011. PMID: 22256471
-
Cytokeratin 7 and cytokeratin 20 in primary urinary bladder carcinoma and matched lymph node metastasis.Arch Pathol Lab Med. 2001 Jul;125(7):921-3. doi: 10.5858/2001-125-0921-CACIPU. Arch Pathol Lab Med. 2001. PMID: 11419977
-
Is esophagogastroduodenoscopy necessary in patients with positive fecal occult blood tests and negative colonoscopy?Scand J Gastroenterol. 2013 Jun;48(6):657-62. doi: 10.3109/00365521.2013.792390. Scand J Gastroenterol. 2013. PMID: 23713803
-
Gastrointestinal and Nongastrointestinal Complications of Esophagogastroduodenoscopy and Colonoscopy in the Real World: A Nationwide Standard Cohort Using the Common Data Model Database.Gut Liver. 2021 Jul 15;15(4):569-578. doi: 10.5009/gnl20222. Gut Liver. 2021. PMID: 33402543 Free PMC article.
-
Comparison of procedural sequence in same-day bidirectional endoscopy: a systematic review and meta-analysis.Korean J Intern Med. 2020 Mar;35(2):331-341. doi: 10.3904/kjim.2019.319. Epub 2019 Dec 27. Korean J Intern Med. 2020. PMID: 31875664 Free PMC article.
Cited by
-
Regular gastroscopy and colonoscopy during the evaluation of urachal cancer: do we really need them?BMC Cancer. 2023 Nov 27;23(1):1156. doi: 10.1186/s12885-023-11531-9. BMC Cancer. 2023. PMID: 38012559 Free PMC article.
References
-
- Milovic M, Popov I, Jelic S. Tumor markers in metastatic disease from cancer of unknown primary origin. Med Sci Monit. 2002;8(2):25–30. - PubMed
-
- Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011;61(4):212–236. - PubMed
-
- Pavlidis N, Briasoulis E, Hainsworth J, Greco FA. Diagnostic and therapeutic management of cancer of an unknown primary. Eur J Cancer. 2003;39(14):1990–2005. - PubMed
-
- Pavlidis N, Pentheroudakis G. Cancer of unknown primary site: 20 questions to be answered. Ann Oncol. 2010;21(Suppl 7):303–307. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials